门诊使用氟哌啶醇成功治疗疑似大麻素呕吐综合征
Successful Treatment of Suspected Cannabinoid Hyperemesis Syndrome Using Haloperidol in the Outpatient Setting.
作者信息
Jones Jennifer L, Abernathy Karen E
机构信息
Departments of Psychiatry and Internal Medicine, Medical University of South Carolina, 67 President Street, Charleston, SC 29425, USA.
Department of Medicine, Division of General Internal Medicine and Geriatrics, Medical University of South Carolina, 135 Rutledge Avenue, Charleston, SC 29425, USA.
出版信息
Case Rep Psychiatry. 2016;2016:3614053. doi: 10.1155/2016/3614053. Epub 2016 Aug 11.
Abstract
Chronic use of cannabis can result in a syndrome of hyperemesis characterized by cyclical vomiting without any other identifiable causes. Cannabinoid hyperemesis syndrome (CHS) is seldom responsive to traditional antiemetic therapies. Despite frequent nausea and vomiting, patients may be reluctant to discontinue use of cannabis. We report a case of severe, refractory CHS with complete resolution of nausea and vomiting after treatment with haloperidol in the outpatient setting. After review of the literature, we believe this is the first reported successful outpatient treatment of CHS and suggests a potential treatment for refractory patients.
摘要
长期使用大麻可导致一种以周期性呕吐为特征的呕吐综合征，且无任何其他可识别的病因。大麻素呕吐综合征（CHS）对传统的止吐疗法很少有反应。尽管频繁出现恶心和呕吐，但患者可能不愿停止使用大麻。我们报告一例严重的难治性CHS病例，在门诊环境中使用氟哌啶醇治疗后，恶心和呕吐完全缓解。在查阅文献后，我们认为这是首次报道的门诊成功治疗CHS的病例，并提示为难治性患者提供了一种潜在的治疗方法。
相似文献
1
Successful Treatment of Suspected Cannabinoid Hyperemesis Syndrome Using Haloperidol in the Outpatient Setting.
Case Rep Psychiatry. 2016;2016:3614053. doi: 10.1155/2016/3614053. Epub 2016 Aug 11.
2
Haloperidol for treatment of cannabinoid hyperemesis syndrome.
Am J Emerg Med. 2013 Jun;31(6):1003.e5-6. doi: 10.1016/j.ajem.2013.02.021. Epub 2013 Apr 10.
3
Cannabinoid-Associated Hyperemesis Syndrome Treated With Dronabinol: Killing a Poison With the Poison.
Cureus. 2023 Nov 29;15(11):e49629. doi: 10.7759/cureus.49629. eCollection 2023 Nov.
4
Comparison of Antiemetics in the Management of Pediatric Cannabinoid Hyperemesis Syndrome.
J Pediatr Pharmacol Ther. 2023;28(3):222-227. doi: 10.5863/1551-6776-28.3.222. Epub 2023 Jun 2.
5
Capsaicin Cream for Treatment of Cannabinoid Hyperemesis Syndrome in Adolescents: A Case Series.
Pediatrics. 2017 Dec;140(6). doi: 10.1542/peds.2016-3795. Epub 2017 Nov 9.
6
Cannabinoid Hyperemesis Syndrome: A Review of Potential Mechanisms.
Cannabis Cannabinoid Res. 2020 Jun 5;5(2):132-144. doi: 10.1089/can.2019.0059. eCollection 2020 Jun 1.
7
Emergency Department Treatment of Cannabinoid Hyperemesis Syndrome: A Review.
Am J Ther. 2018 May/Jun;25(3):e357-e361. doi: 10.1097/MJT.0000000000000655.
8
Is haloperidol the wonder drug for cannabinoid hyperemesis syndrome?
BMJ Case Rep. 2017 Jan 4;2017:bcr2016218239. doi: 10.1136/bcr-2016-218239.
9
Resolution of Cannabinoid Hyperemesis Syndrome with Benzodiazepines: A Case Series.
Isr Med Assoc J. 2019 Jun;21(6):404-407.
10
The utility of droperidol in the treatment of cannabinoid hyperemesis syndrome.
Clin Toxicol (Phila). 2019 Sep;57(9):773-777. doi: 10.1080/15563650.2018.1564324. Epub 2019 Feb 7.
引用本文的文献
1
Cannabis Hyperemesis Syndrome: What Do We Know?
Med Cannabis Cannabinoids. 2024 May 3;7(1):86-90. doi: 10.1159/000539182. eCollection 2024 Jan-Dec.
2
Comparison of Antiemetics in the Management of Pediatric Cannabinoid Hyperemesis Syndrome.
J Pediatr Pharmacol Ther. 2023;28(3):222-227. doi: 10.5863/1551-6776-28.3.222. Epub 2023 Jun 2.
3
Reply to Letter "Cannabis-Related Cyclic/Episodic Hyperemesis Conditions: From Suspected to Definitive Cannabinoid Hyperemesis Syndrome".
Med Princ Pract. 2022;31(5):499-500. doi: 10.1159/000525992. Epub 2022 Jul 11.
4
Death of a young woman with cyclic vomiting: a case report.
Forensic Sci Med Pathol. 2021 Dec;17(4):715-722. doi: 10.1007/s12024-021-00410-z. Epub 2021 Nov 4.
5
A Systematic Review on Cannabis Hyperemesis Syndrome and Its Management Options.
Med Princ Pract. 2022;31(1):29-38. doi: 10.1159/000520417. Epub 2021 Nov 1.
6
Cannabinoid Hyperemesis.
Med Cannabis Cannabinoids. 2018 Nov 15;1(2):73-95. doi: 10.1159/000494992. eCollection 2019 Jan.
7
Management of Pediatric Cannabinoid Hyperemesis Syndrome: A Review.
J Pediatr Pharmacol Ther. 2021;26(4):339-345. doi: 10.5863/1551-6776-26.4.339. Epub 2021 May 19.
8
Marijuana: A systems-based primer of adverse effects associated with use and an overview of its therapeutic utility.
SAGE Open Med. 2021 Mar 9;9:20503121211000909. doi: 10.1177/20503121211000909. eCollection 2021.
9
Topical Capsaicin for Treating Cannabinoid Hyperemesis Syndrome.
Case Rep Gastrointest Med. 2020 Nov 27;2020:8868385. doi: 10.1155/2020/8868385. eCollection 2020.
10
Cannabinoids for Treatment of MS Symptoms: State of the Evidence.
Curr Neurol Neurosci Rep. 2018 Jun 19;18(8):50. doi: 10.1007/s11910-018-0859-x.
本文引用的文献
1
An Overlooked Victim of Cannabis: Losing Several Years of Well-being and Inches of Jejunum on the Way to Unravel Her Hyperemesis Enigma.
Clin Neuropharmacol. 2016 Jan-Feb;39(1):53-4. doi: 10.1097/WNF.0000000000000118.
2
An Internet survey of marijuana and hot shower use in adults with cyclic vomiting syndrome (CVS).
Exp Brain Res. 2014 Aug;232(8):2563-70. doi: 10.1007/s00221-014-3967-0. Epub 2014 May 4.
3
A rare case of cannabis hyperemesis syndrome relieved by hot water bathing.
Clin Med (Lond). 2014 Feb;14(1):86-7. doi: 10.7861/clinmedicine.14-1-86.
4
Haloperidol for treatment of cannabinoid hyperemesis syndrome.
Am J Emerg Med. 2013 Jun;31(6):1003.e5-6. doi: 10.1016/j.ajem.2013.02.021. Epub 2013 Apr 10.
5
Cannabinoid hyperemesis: a case series of 98 patients.
Mayo Clin Proc. 2012 Feb;87(2):114-9. doi: 10.1016/j.mayocp.2011.10.005.
6
Cannabinoid hyperemesis syndrome.
Curr Drug Abuse Rev. 2011 Dec;4(4):241-9. doi: 10.2174/1874473711104040241.
7
Cannabinoid hyperemesis syndrome: literature review and proposed diagnosis and treatment algorithm.
South Med J. 2011 Sep;104(9):659-64. doi: 10.1097/SMJ.0b013e3182297d57.
8
Spectrum of gastric emptying patterns in adult patients with cyclic vomiting syndrome.
Neurogastroenterol Motil. 2010 Dec;22(12):1298-302, e338. doi: 10.1111/j.1365-2982.2010.01584.x. Epub 2010 Aug 19.
9
Delta9-tetrahydrocannbinol accounts for the antinociceptive, hypothermic, and cataleptic effects of marijuana in mice.
J Pharmacol Exp Ther. 2005 Jul;314(1):329-37. doi: 10.1124/jpet.104.080739. Epub 2005 Apr 14.
10
Cannabinoid hyperemesis: cyclical hyperemesis in association with chronic cannabis abuse.
Gut. 2004 Nov;53(11):1566-70. doi: 10.1136/gut.2003.036350.
Zotero 插件